LOCALIZED THYMIC LANGERHANS CELL HISTIOCYTOSIS AND ITS RELATIONSHIP WITH MYASTHENIA-GRAVIS - IMMUNOHISTOCHEMICAL, ULTRASTRUCTURAL, AND CYTOMETRIC STUDIES

Citation
Mz. Gilcrease et al., LOCALIZED THYMIC LANGERHANS CELL HISTIOCYTOSIS AND ITS RELATIONSHIP WITH MYASTHENIA-GRAVIS - IMMUNOHISTOCHEMICAL, ULTRASTRUCTURAL, AND CYTOMETRIC STUDIES, Archives of pathology and laboratory medicine, 121(2), 1997, pp. 134-138
Citations number
14
Categorie Soggetti
Pathology,"Medical Laboratory Technology","Medicine, Research & Experimental
Journal title
Archives of pathology and laboratory medicine
ISSN journal
00039985 → ACNP
Volume
121
Issue
2
Year of publication
1997
Pages
134 - 138
Database
ISI
SICI code
0003-9985(1997)121:2<134:LTLCHA>2.0.ZU;2-J
Abstract
Objective.-It has been suggested that localized Langerhans' cell histi ocytosis may represent an exaggerated form of a proliferative process that has been reported in a few patients with myasthenia gravis. To ev aluate the relationship between thymic Langerhans' cell proliferation and myasthenia gravis, we analyzed a rare case of localized thymic Lan gerhans' cell histiocytosis and examined thymic Langerhans' cell distr ibution in myasthenic and control patients. Design.-Immunohistochemica l, ultrastructural, and image cytometric DNA analyses were performed o n the index case. Immunostaining for S100 was performed on 20 addition al thymuses, 10 from patients with myasthenia gravis and 10 from contr ol patients. Results.-Immunohistochemical studies revealed no increase in Langerhans' cells in the surrounding thymic tissue of the index ca se. No difference was found between the number of Langerhans' cells in the remaining thymuses of myasthenia patients compared with the contr ol group, and no micronodular proliferations were identified in either group. Conclusions.-Localized thymic Langerhans' cell histiocytosis i s an unusual lesion that is associated with myasthenia gravis in some patients. In the few cases reported at present, however, the lesion do es not appear to be related pathogenetically to myasthenia gravis.